Azenta, Inc. (AZTA)
USD 49.65
(7.21%)
USD 49.65
(7.21%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -73.12 Million USD | -1726.78% |
| 2022 | -4 Million USD | 91.4% |
| 2021 | -46.54 Million USD | -159.33% |
| 2020 | 78.45 Million USD | 68.6% |
| 2019 | 46.53 Million USD | 48.16% |
| 2018 | 31.4 Million USD | -51.01% |
| 2017 | 64.11 Million USD | 1412.81% |
| 2016 | 4.23 Million USD | -74.91% |
| 2015 | 16.89 Million USD | 725.79% |
| 2014 | -2.69 Million USD | 70.07% |
| 2013 | -9.01 Million USD | -194.33% |
| 2012 | 9.56 Million USD | -87.99% |
| 2011 | 79.59 Million USD | 69.33% |
| 2010 | 47 Million USD | 120.61% |
| 2009 | -228.02 Million USD | 3.98% |
| 2008 | -237.46 Million USD | -688.51% |
| 2007 | 40.35 Million USD | 45.23% |
| 2006 | 27.78 Million USD | 1105.57% |
| 2005 | -2.76 Million USD | -108.8% |
| 2004 | 31.4 Million USD | 119.83% |
| 2003 | -158.39 Million USD | 74.77% |
| 2002 | -627.81 Million USD | -1329.98% |
| 2001 | -43.9 Million USD | -351.99% |
| 2000 | 17.42 Million USD | 309.92% |
| 1999 | -8.3 Million USD | 61.75% |
| 1998 | -21.7 Million USD | -2270.0% |
| 1997 | 1 Million USD | -92.31% |
| 1996 | 13 Million USD | 96.97% |
| 1995 | 6.6 Million USD | 164.0% |
| 1994 | 2.5 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -26.67 Million USD | -60.43% |
| 2024 Q3 | -12.69 Million USD | 57.55% |
| 2024 Q2 | -23.63 Million USD | 11.4% |
| 2023 Q3 | -15.83 Million USD | 44.67% |
| 2023 FY | -73.12 Million USD | -1726.78% |
| 2023 Q1 | -26.22 Million USD | -84.23% |
| 2023 Q4 | -16.62 Million USD | -5.0% |
| 2023 Q2 | -28.62 Million USD | -9.15% |
| 2022 Q2 | -4.58 Million USD | -1311.08% |
| 2022 FY | -4 Million USD | 91.4% |
| 2022 Q1 | -325 Thousand USD | 98.47% |
| 2022 Q4 | -14.23 Million USD | -692.1% |
| 2022 Q3 | 2.4 Million USD | 152.42% |
| 2021 Q2 | 30.5 Million USD | -1.37% |
| 2021 FY | -46.54 Million USD | -159.33% |
| 2021 Q4 | -21.24 Million USD | -142.29% |
| 2021 Q3 | 50.23 Million USD | 64.67% |
| 2021 Q1 | 30.92 Million USD | -9.36% |
| 2020 Q4 | 34.12 Million USD | 78.65% |
| 2020 Q1 | 10.66 Million USD | -3.99% |
| 2020 Q3 | 19.09 Million USD | 31.07% |
| 2020 FY | 78.45 Million USD | 68.6% |
| 2020 Q2 | 14.57 Million USD | 36.62% |
| 2019 Q4 | 11.1 Million USD | -32.36% |
| 2019 Q1 | 5.33 Million USD | 47.48% |
| 2019 Q3 | 16.42 Million USD | 20.12% |
| 2019 Q2 | 13.67 Million USD | 156.37% |
| 2019 FY | 46.53 Million USD | 48.16% |
| 2018 Q2 | 23.81 Million USD | 14.29% |
| 2018 FY | 31.4 Million USD | -51.01% |
| 2018 Q1 | 20.84 Million USD | 19.9% |
| 2018 Q3 | 26.67 Million USD | 12.01% |
| 2018 Q4 | 3.61 Million USD | -86.45% |
| 2017 FY | 64.11 Million USD | 1412.81% |
| 2017 Q3 | 18.77 Million USD | 26.82% |
| 2017 Q4 | 17.38 Million USD | -7.4% |
| 2017 Q2 | 14.8 Million USD | 12.46% |
| 2017 Q1 | 13.16 Million USD | 26.5% |
| 2016 FY | 4.23 Million USD | -74.91% |
| 2016 Q3 | 8.49 Million USD | 234.0% |
| 2016 Q2 | -6.33 Million USD | 23.81% |
| 2016 Q1 | -8.32 Million USD | -181.99% |
| 2016 Q4 | 10.4 Million USD | 22.49% |
| 2015 FY | 16.89 Million USD | 725.79% |
| 2015 Q3 | 10.17 Million USD | 233.11% |
| 2015 Q2 | 3.05 Million USD | 147.11% |
| 2015 Q4 | 10.14 Million USD | -0.23% |
| 2015 Q1 | -6.48 Million USD | -907.78% |
| 2014 Q1 | 3.94 Million USD | 528.71% |
| 2014 Q2 | 2.39 Million USD | -39.22% |
| 2014 Q4 | -643 Thousand USD | 89.12% |
| 2014 Q3 | -5.91 Million USD | -346.66% |
| 2014 FY | -2.69 Million USD | 70.07% |
| 2013 Q2 | -972 Thousand USD | 92.56% |
| 2013 FY | -9.01 Million USD | -194.33% |
| 2013 Q4 | 627 Thousand USD | -85.72% |
| 2013 Q3 | 4.39 Million USD | 551.65% |
| 2013 Q1 | -13.06 Million USD | -51.17% |
| 2012 Q2 | 8.41 Million USD | 475.19% |
| 2012 Q3 | 8.32 Million USD | -1.07% |
| 2012 Q4 | -8.64 Million USD | -203.81% |
| 2012 FY | 9.56 Million USD | -87.99% |
| 2012 Q1 | 1.46 Million USD | -78.96% |
| 2011 Q2 | 26.74 Million USD | 12.69% |
| 2011 FY | 79.59 Million USD | 69.33% |
| 2011 Q4 | 6.95 Million USD | -68.63% |
| 2011 Q1 | 23.72 Million USD | 6.22% |
| 2011 Q3 | 22.17 Million USD | -17.09% |
| 2010 Q1 | -1.79 Million USD | 87.7% |
| 2010 FY | 47 Million USD | 120.61% |
| 2010 Q2 | 9.94 Million USD | 653.84% |
| 2010 Q3 | 16.51 Million USD | 66.04% |
| 2010 Q4 | 22.34 Million USD | 35.26% |
| 2009 FY | -228.02 Million USD | 3.98% |
| 2009 Q4 | -14.59 Million USD | 43.61% |
| 2009 Q3 | -25.88 Million USD | 83.07% |
| 2009 Q1 | -34.62 Million USD | 84.02% |
| 2009 Q2 | -152.91 Million USD | -341.6% |
| 2008 FY | -237.46 Million USD | -688.51% |
| 2008 Q4 | -216.64 Million USD | -2152.05% |
| 2008 Q3 | -9.62 Million USD | -27.99% |
| 2008 Q2 | -7.51 Million USD | -103.91% |
| 2008 Q1 | -3.68 Million USD | 28.27% |
| 2007 FY | 40.35 Million USD | 45.23% |
| 2007 Q4 | -5.13 Million USD | -135.98% |
| 2007 Q3 | 14.28 Million USD | -8.49% |
| 2007 Q2 | 15.61 Million USD | 0.09% |
| 2007 Q1 | 15.59 Million USD | -7.87% |
| 2006 Q1 | -11.11 Million USD | -36.28% |
| 2006 FY | 27.78 Million USD | 1105.57% |
| 2006 Q3 | 16.24 Million USD | 161.83% |
| 2006 Q2 | 6.2 Million USD | 155.84% |
| 2006 Q4 | 16.92 Million USD | 4.22% |
| 2005 Q3 | 1.84 Million USD | 281.89% |
| 2005 Q1 | 1.36 Million USD | -88.45% |
| 2005 FY | -2.76 Million USD | -108.8% |
| 2005 Q4 | -8.15 Million USD | -541.18% |
| 2005 Q2 | -1.01 Million USD | -174.65% |
| 2004 Q2 | 9.7 Million USD | -73.63% |
| 2004 Q4 | 11.78 Million USD | -28.36% |
| 2004 Q1 | 36.77 Million USD | 176.35% |
| 2004 Q3 | 16.45 Million USD | 69.6% |
| 2004 FY | 31.4 Million USD | 119.83% |
| 2003 Q1 | -52.54 Million USD | 90.53% |
| 2003 FY | -158.39 Million USD | 74.77% |
| 2003 Q4 | -48.16 Million USD | -42.14% |
| 2003 Q3 | -33.88 Million USD | -42.43% |
| 2003 Q2 | -23.79 Million USD | 54.72% |
| 2002 FY | -627.81 Million USD | -1329.98% |
| 2002 Q1 | -12.65 Million USD | 73.69% |
| 2002 Q2 | -17.04 Million USD | -34.63% |
| 2002 Q3 | -38.59 Million USD | -126.44% |
| 2002 Q4 | -555.06 Million USD | -1338.36% |
| 2001 Q2 | 1.28 Million USD | -82.08% |
| 2001 Q4 | -48.11 Million USD | -1033.28% |
| 2001 Q3 | -4.24 Million USD | -430.17% |
| 2001 FY | -43.9 Million USD | -351.99% |
| 2001 Q1 | 7.17 Million USD | 137.43% |
| 2000 Q4 | 3.02 Million USD | -39.87% |
| 2000 Q1 | 4.1 Million USD | 163.08% |
| 2000 Q3 | 5.02 Million USD | 18.54% |
| 2000 Q2 | 4.24 Million USD | 3.41% |
| 2000 FY | 17.42 Million USD | 309.92% |
| 1999 FY | -8.3 Million USD | 61.75% |
| 1999 Q4 | -6.5 Million USD | -6400.0% |
| 1999 Q3 | -100 Thousand USD | 80.0% |
| 1999 Q2 | -500 Thousand USD | 54.55% |
| 1999 Q1 | -1.1 Million USD | 90.35% |
| 1998 Q2 | -7.4 Million USD | -572.73% |
| 1998 Q1 | -1.1 Million USD | -150.0% |
| 1998 FY | -21.7 Million USD | -2270.0% |
| 1998 Q4 | -11.4 Million USD | -500.0% |
| 1998 Q3 | -1.9 Million USD | 74.32% |
| 1997 Q3 | 700 Thousand USD | 136.84% |
| 1997 Q2 | -1.9 Million USD | -2000.0% |
| 1997 Q4 | 2.2 Million USD | 214.29% |
| 1997 FY | 1 Million USD | -92.31% |
| 1997 Q1 | 100 Thousand USD | -96.88% |
| 1996 Q4 | 3.2 Million USD | -15.79% |
| 1996 FY | 13 Million USD | 96.97% |
| 1996 Q3 | 3.8 Million USD | 18.75% |
| 1996 Q2 | 3.2 Million USD | -80.95% |
| 1996 Q1 | 16.8 Million USD | 168.29% |
| 1995 FY | 6.6 Million USD | 164.0% |
| 1995 Q4 | -24.6 Million USD | -293.7% |
| 1995 Q2 | 10 Million USD | 19.05% |
| 1995 Q3 | 12.7 Million USD | 27.0% |
| 1995 Q1 | 8.4 Million USD | 0.0% |
| 1994 FY | 2.5 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | -26.805% |
| AngioDynamics, Inc. | -97.71 Million USD | 25.166% |
| AtriCure, Inc. | -26.68 Million USD | -174.055% |
| Avinger, Inc. | -16.63 Million USD | -339.591% |
| BioLife Solutions, Inc. | -70.82 Million USD | -3.249% |
| The Cooper Companies, Inc. | 533.1 Million USD | 113.717% |
| Daxor Corporation | -177.07 Thousand USD | -41196.626% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | -383.894% |
| Femasys Inc. | -14.5 Million USD | -404.025% |
| GlucoTrack, Inc. | -7.1 Million USD | -929.364% |
| Harvard Bioscience, Inc. | 1.89 Million USD | 3960.929% |
| Hologic, Inc. | 882.6 Million USD | 108.285% |
| ICU Medical, Inc. | 22.82 Million USD | 420.377% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 104.139% |
| KORU Medical Systems, Inc. | -10.26 Million USD | -612.037% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | 297.201% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -959.714% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -959.714% |
| Masimo Corporation | 136.5 Million USD | 153.572% |
| Microbot Medical Inc. | -9.85 Million USD | -642.019% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | 598.305% |
| Merit Medical Systems, Inc. | 123.94 Million USD | 158.999% |
| Nephros, Inc. | -1.59 Million USD | -4490.458% |
| NovoCure Limited | -232.87 Million USD | 68.598% |
| NEXGEL, Inc. | -3.47 Million USD | -2003.135% |
| NEXGEL, Inc. | -3.47 Million USD | -2003.135% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 28.866% |
| OraSure Technologies, Inc. | 54.07 Million USD | 235.221% |
| Pro-Dex, Inc. | 7.17 Million USD | 1119.462% |
| Pulse Biosciences, Inc. | -43.57 Million USD | -67.82% |
| Predictive Oncology Inc. | -13.92 Million USD | -425.28% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | -2584.18% |
| QuidelOrtho Corporation | 139.1 Million USD | 152.571% |
| Repligen Corporation | 54.57 Million USD | 233.989% |
| Sanara MedTech Inc. | -4.21 Million USD | -1634.836% |
| STAAR Surgical Company | 28.09 Million USD | 360.263% |
| Sharps Technology, Inc. | -10.12 Million USD | -622.114% |
| Utah Medical Products, Inc. | 16.77 Million USD | 535.871% |
| DENTSPLY SIRONA Inc. | -85 Million USD | 13.969% |
| Jin Medical International Ltd. | 2.86 Million USD | 2650.377% |